1. Home
  2. RYTM vs BKH Comparison

RYTM vs BKH Comparison

Compare RYTM & BKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • BKH
  • Stock Information
  • Founded
  • RYTM 2008
  • BKH 1941
  • Country
  • RYTM United States
  • BKH United States
  • Employees
  • RYTM N/A
  • BKH N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • BKH Electric Utilities: Central
  • Sector
  • RYTM Health Care
  • BKH Utilities
  • Exchange
  • RYTM Nasdaq
  • BKH Nasdaq
  • Market Cap
  • RYTM 3.8B
  • BKH 4.3B
  • IPO Year
  • RYTM 2017
  • BKH N/A
  • Fundamental
  • Price
  • RYTM $61.33
  • BKH $58.48
  • Analyst Decision
  • RYTM Strong Buy
  • BKH Hold
  • Analyst Count
  • RYTM 12
  • BKH 4
  • Target Price
  • RYTM $76.75
  • BKH $63.75
  • AVG Volume (30 Days)
  • RYTM 632.6K
  • BKH 448.6K
  • Earning Date
  • RYTM 05-07-2025
  • BKH 05-07-2025
  • Dividend Yield
  • RYTM N/A
  • BKH 4.63%
  • EPS Growth
  • RYTM N/A
  • BKH N/A
  • EPS
  • RYTM N/A
  • BKH 3.95
  • Revenue
  • RYTM $136,863,000.00
  • BKH $2,206,500,000.00
  • Revenue This Year
  • RYTM $37.88
  • BKH $7.02
  • Revenue Next Year
  • RYTM $72.84
  • BKH $3.29
  • P/E Ratio
  • RYTM N/A
  • BKH $14.79
  • Revenue Growth
  • RYTM 48.88
  • BKH 3.28
  • 52 Week Low
  • RYTM $35.35
  • BKH $51.66
  • 52 Week High
  • RYTM $68.58
  • BKH $65.59
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 51.78
  • BKH 47.15
  • Support Level
  • RYTM $58.72
  • BKH $57.37
  • Resistance Level
  • RYTM $63.24
  • BKH $58.88
  • Average True Range (ATR)
  • RYTM 2.43
  • BKH 0.98
  • MACD
  • RYTM -0.15
  • BKH -0.03
  • Stochastic Oscillator
  • RYTM 65.51
  • BKH 64.62

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About BKH Black Hills Corporation

Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.

Share on Social Networks: